We propose a model (Figure 5) where, after CySC ablation, hub cell proliferation and conversion to CySCs are driven by EGFR signaling, promoted by a new signal (EGF ligands from germ cells) not normally received by the hub, and by loss of an existing signal (the EGFR inhibitor Argos from cyst lineage cells). Here, EGF is linked to cyst.